Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1966 Jul;45(7):1093–1102. doi: 10.1172/JCI105415

The relationship of parathyroid activity to pyrophosphate excretion.

L V Avioli, J E McDonald, P H Henneman, S W Lee
PMCID: PMC292781  PMID: 4290912

Full text

PDF
1093

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AVIOLI L. V., MCDONALD J. E., SINGER R. A. EXCRETION OF PYROPHOSPHATE IN DISORDERS OF BONE METABOLISM. J Clin Endocrinol Metab. 1965 Jul;25:912–915. doi: 10.1210/jcem-25-7-912. [DOI] [PubMed] [Google Scholar]
  2. BENOIT F. L., THEIL G. B., WATTEN R. H. HYDROXYPROLINE EXCRETION IN ENDOCRINE DISEASE. Metabolism. 1963 Dec;12:1072–1082. [PubMed] [Google Scholar]
  3. CARTIER P., PICARD J. La minéralisation du cartilage ossifiable. I. La minéralisation du cartilage in vitro. Bull Soc Chim Biol (Paris) 1955;37(4):485–494. [PubMed] [Google Scholar]
  4. CHANG H. Y. Grafts of parathyroid and other tissues to bone. Anat Rec. 1951 Sep;111(1):23–47. doi: 10.1002/ar.1091110103. [DOI] [PubMed] [Google Scholar]
  5. EISENBERG E. EFFECTS OF SERUM CALCIUM LEVEL AND PARATHYROID EXTRACTS ON PHOSPHATE AND CALCIUM EXCRETION IN HYPOPARATHYROID PATIENTS. J Clin Invest. 1965 Jun;44:942–946. doi: 10.1172/JCI105211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FLEISCH H., BISAZ S., CARE A. D. EFFECT OF ORTHOPHOSPHATE ON URINARY PYROPHOSPHATE EXCRETION AND THE PREVENTION OF UROLITHIASIS. Lancet. 1964 May 16;1(7342):1065–1067. doi: 10.1016/s0140-6736(64)91267-x. [DOI] [PubMed] [Google Scholar]
  7. FLEISCH H., BISAZ S. Isolation from urine of pyrophosphate, a calcification inhibitor. Am J Physiol. 1962 Oct;203:671–675. doi: 10.1152/ajplegacy.1962.203.4.671. [DOI] [PubMed] [Google Scholar]
  8. FLEISCH H., BISAZ S. Mechanism of calcification: inhibitory role of pyrophosphate. Nature. 1962 Sep 1;195:911–911. doi: 10.1038/195911a0. [DOI] [PubMed] [Google Scholar]
  9. GOLDMAN R., BASSETT S. H. Effect of intravenous calcium gluconate upon the excretion of calcium and phosphorus in patients with idiopathic hypoparathyroidism. J Clin Endocrinol Metab. 1954 Mar;14(3):278–286. doi: 10.1210/jcem-14-3-278. [DOI] [PubMed] [Google Scholar]
  10. HIATT H. H., THOMPSON D. D. Some effects of intravenously administered calcium on inorganic phosphate metabolism. J Clin Invest. 1957 Apr;36(4):573–580. doi: 10.1172/JCI103456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HOWARD J. E., HOPKINS T. R., CONNOR T. B. On certain physiologic responses to intravenous injection of calcium salts into normal hyperparathyroid and hypoparathyroid persons. J Clin Endocrinol Metab. 1953 Jan;13(1):1–19. doi: 10.1210/jcem-13-1-1. [DOI] [PubMed] [Google Scholar]
  12. KEISER H. R., GILL J. R., Jr, SJOERDSMA A., BARTTER F. C. RELATION BETWEEN URINARY HYDROXYPROLINE AND PARATHYROID FUNCTION. J Clin Invest. 1964 Jun;43:1073–1082. doi: 10.1172/JCI104991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. KLEIN L., LAFFERTY F. W., PEARSON O. H., CURTISS P. H., Jr CORRELATION OF URINARY HYDROXYPROLINE, SERUM ALKALINE PHOSPHATASE AND SKELETAL CALCIUM TURNOVER. Metabolism. 1964 Mar;13:272–284. doi: 10.1016/0026-0495(64)90106-4. [DOI] [PubMed] [Google Scholar]
  14. KRANE S. M., GLIMCHER M. J. Transphosphorylation from nucleoside Di- and triphosphates by apatite crystals. J Biol Chem. 1962 Sep;237:2991–2998. [PubMed] [Google Scholar]
  15. KYLE L. H., SCHAAF M., ERDMAN L. A. The metabolic effects of intravenous administration of calcium. J Lab Clin Med. 1954 Jan;43(1):123–133. [PubMed] [Google Scholar]
  16. PERKINS H. R., WALKER P. G. The occurrence of pyrophosphate in bone. J Bone Joint Surg Br. 1958 May;40-B(2):333–339. doi: 10.1302/0301-620X.40B2.333. [DOI] [PubMed] [Google Scholar]
  17. PROCKOP D. J. ISOTOPIC STUDIES ON COLLAGEN DEGRADATION AND THE URINE EXCRETION OF HYDROXYPROLINE. J Clin Invest. 1964 Mar;43:453–460. doi: 10.1172/JCI104930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. PROCKOP D. J., UDENFRIEND S. A specific method for the analysis of hydroxyproline in tissues and urine. Anal Biochem. 1960 Nov;1:228–239. doi: 10.1016/0003-2697(60)90050-6. [DOI] [PubMed] [Google Scholar]
  19. PULLMAN T. N., LAVENDER A. R., AHO I., RASMUSSEN H. Direct renal action of a purified parathyroid extract. Endocrinology. 1960 Nov;67:570–582. doi: 10.1210/endo-67-5-570. [DOI] [PubMed] [Google Scholar]
  20. RUSSELL R. G., EDWARDS N. A., HODGKINSON A. URINARY PYROPHOSPHATE AND UROLITHIASIS. Lancet. 1964 Jun 27;2(7348):1446–1446. doi: 10.1016/s0140-6736(64)92014-8. [DOI] [PubMed] [Google Scholar]
  21. STETTEN D., Jr Biosynthesis and pyrophosphate. Am J Med. 1960 Jun;28:867–870. doi: 10.1016/0002-9343(60)90195-9. [DOI] [PubMed] [Google Scholar]
  22. STETTEN M. R. METABOLISM OF INORGANIC PYROPHOSPHATE. 3. ACCEPTOR SPECIFICITY STUDIES WITH RAT LIVER MICROSOMAL PYROPHOSPHATE PHOSPHOTRANSFERASE ACTIVITY. J Biol Chem. 1965 May;240:2248–2253. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES